EMN | MSCNET | BDR-WM TRIAL

Membership


Register as a free member of the European Myeloma Network

On behalf of the European Myeloma Network (EMN) we hereby invite you to be a full member of our organization.

As one of the leading Scientists in the field of Myeloma you will benefit from a membership by the close contact and collaboration with an active and focused European organization.

The EMN is a non-profit organization. Its aims are to promote all aspects associated with Multiple Myeloma including basic and clinical research, standardization, quality control, education and dissemination of results.

The membership fee is 0 Euro per annum for full membership of individual members. Please register your membership by completing this Registration Form.

Individual EMN members

Individual Members of the EMN are actively involved in MM research, or involved in the care of patients. Members should hold a degree (MD, Ph D, nursing degree, others) and demonstrate an expertise in MM. This should be proven by two years working experience in activities related to the aims of EMN. Applicants should be presented by two EMN Members.

To become an individual EMN member one must be actively involved in MM research, either in the laboratory or in the clinic or in other activities closely related and relevant. An EMN member has the following rights:

  1. To participate in EMN studies and activities of the Task Forces.
  2. To stand for election.
  3. To receive information about the Board and other activities, co-operative studies, and results of EMN research projects.
  4. To have access to the EMN WEB site and to statistical overviews of registered data.
  5. To receive yearly survey of EMN activity
  6. To receive EMN news
  7. To submit data for presentation at the annual meeting.
  8. To be eligible for a reduced fee to attend the Annual Meeting of the EMN.

Corporate Membership

For more information about corporate membership please visit our sponsorship page.

The European Myeloma Network
Terms of use
Last Update: 19th January 2007